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Abstract We have cloned two isoforms of cDNAs encoding
novel zinc finger proteins. One form encodes a 274-amino acid
protein containing an acidic amino acid and serine-rich domain
and a zinc finger domain which shows high sequence homology to
that of Drosophila Ovo protein. The other form encodes a
179-amino acid protein containing only the zinc finger domain.
Expression of both proteins possessing an antigenic epitope in
COS cells revealed that they are localized in the nucleus. The
1.3-kbp mRNAs are predominantly expressed in testis, and the
expression increases from 3 weeks postnatal, implying that these
proteins may play important roles in the development of the
testes.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The development of multicellular organisms is controlled by
sequential activation of a hierarchy of regulatory genes, which
encode transcription factors having multiple classes of DNA
binding motifs. The zinc ¢nger is the most common DNA
binding motif among eukaryotic transcription factors, and is
classi¢ed based on its amino acid sequence involved in the
zinc chelation into several subgroups: C2H2, C4, C2HC and
C6 groups [1^5].
Zinc ¢nger coding sequences have been found in a number
of the genes that control Drosophila development. The genes
kruºppel, hunchback, huckebein and buttonhead are crucial for
the proper segmentation of the developing embryo [6^9].
ovo is required for survival and di¡erentiation of female
germ line cells and plays an important role in germ line sex
determination in Drosophila [10^14]. Homologous null mu-
tants produce rudimentary ovaries in which germ cells have
completely degenerated, leaving only somatic tissues [10]. Less
severe mutations produce viable germ cells that exhibit defec-
tive oogenesis [10] or ovarian tumors with male germ line
features [10,12]. The three dominant female-sterile alleles ei-
ther arrest oogenesis at previtellogenic stages or allow the
production of defective eggs [15]. MeŁvel-Ninio et al. identi¢ed
a genomic fragment that rescues ovo mutation and isolated
cDNA clones of the locus [16]. The molecular structure of the
ovo gene product contains four C2H2 zinc ¢nger motifs, sug-
gesting that ovo encodes a transcription factor [16^19].
Since molecular mechanisms regulating development and
cell di¡erentiation are partly conserved between Drosophila
and mammals, isolation of mammalian homologues or closely
related genes of Drosophila genes provides useful clues for
elucidating those processes in mammals.
In this study, we report the isolation of two cDNA clones
encoding novel proteins that possess a zinc ¢nger domain
highly homologous to that of Drosophila Ovo protein. We
found that these proteins were localized in the nuclei and
that the mRNAs were predominantly expressed in testis and
developmentally regulated.
2. Materials and methods
2.1. Isolation of cDNA clones and DNA sequencing
A mouse testis cDNA library was constructed in V Zap II by the
method of Huynh et al. [20]. The DNA fragment corresponding to the
zinc ¢nger domain of Drosophila ovo protein (between amino acids
932 and 1152 [16]) was ampli¢ed by the polymerase chain reaction
(PCR), and labeled with 32P by random priming. Hybridization was
carried out at 42‡C with 5USSPE, 0.1% SDS, 1UDenhardt’s solu-
tion, 50% dextran sulfate, 0.1 mg/ml denatured salmon sperm DNA
and 2U106 cpm/ml probe. The highest stringency wash was 2USSC-
0.1% SDS at 42‡C. Out of a screening of 5U105 phages, 11 positive
plaques were isolated and excised from the V Zap II vector according
to the supplier’s directions (Stratagene). The plasmid clones were
grouped into two (two and nine clones) by DNA sequencing. The
longest clones of each group were designated M-OVO-A and M-
OVO-B and analyzed.
2.2. Transient expression of epitope-tagged M-OVO
The entire coding regions of M-OVO-A and -B were ampli¢ed
using PCR with sense oligonucleotides containing an XbaI site: 5P-
GCTCTAGAATGCCCAAAGTCTTTCTGGTA-3P for M-OVO-A
and 5P-GCTCTAGAATGCAGCGCCCGGTTGCCAGG-3P for M-
OVO-B; and antisense oligonucleotides containing a HindIII site:
5P-CTCTAAGCTTTTTTTCCTCCTCTTCACTC-3P for both clones.
The restriction sites facilitate subcloning the ampli¢ed sequences into
pCG-HA [21] so that the in£uenza virus hemagglutinin (HA) epitope
(GYPYDVPDYA) would attach to the amino-terminus of M-OVO-A
and -B, designated pCG-HA-M-OVO-A and pCG-HA-M-OVO-B,
respectively. COS-7 cells were transfected by the calcium-phosphate
method [22]. Forty-eight hours later, the cells were ¢xed in 100%
methanol at 320‡C for 10 min. The cells were incubated for 2 h at
room temperature with a 1:100 dilution of mouse ascites £uid con-
taining 12CA5 monoclonal antibody directed against the in£uenza
HA epitope (Boehringer Mannheim). The cells were washed with
PBS and then incubated for 1 h with a 1:50 dilution of rhodamine-
conjugated goat anti-mouse IgG (Kirkegaard p Perry Laboratories
Inc., Gaithersburg, MD). Following several washes with PBS, the cells
were viewed with a £uorescence microscope (Olympus GB 200).
2.3. Northern blot analysis
Total RNA and poly(A) RNA of mouse tissues were isolated and
analyzed according to standard procedures [23]. The 369-bp PstI frag-
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Fig. 1. Nucleotide and predicted amino acid sequences of M-OVO-A (A) and 5P region of M-OVO-B (B). The region of overlap between two
clones is indicated by square brackets. The polyadenylation signal is double underlined. In the amino acid sequence, the zinc ¢nger motif is
thick underlined, an acidic amino acid/serine-rich domain is underlined. The methionine as an initiation codon of M-OVO-B is indicated by an
asterisk. Numbers in the left and right margins refer to nucleotide and amino acid positions, respectively.
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ment which includes the zinc ¢nger domain region of M-OVO cDNA
was labeled with 32P by random priming. Hybridization was per-
formed at 42‡C overnight in 5USSC bu¡er with 50% formamide,
1UDenhardt’s solution, 1% SDS, 0.1 mg/ml denatured salmon sperm
DNA, and 1 ng/ml probe. The ¢lters were washed twice in 2USSC-
0.1% SDS at room temperature for 20 min and once in 0.1USSC-
0.1% SDS at 55‡C for 30 min.
3. Results and discussion
Northern hybridization analysis of various mouse tissues
with the DNA fragment corresponding to the zinc ¢nger do-
main of Ovo protein as a probe yielded a faint signal in testis
(data not shown). Therefore, we screened a testis cDNA li-
brary under low stringency. We isolated two di¡erent groups
of clones which were designated M-OVO-A and M-OVO-B.
DNA sequencing analysis of the longest clone of each group
revealed that the two cDNA clones are di¡erent in a small
part of the 5P-terminal region, but the other 1154 nucleotides
spanning to the poly(A) tail are completely identical (Fig. 1).
Genomic Southern blot analysis with a DNA fragment of the
common 3P end part of two clones as a probe revealed that a
single band was detected in the genome digested by multiple
restriction enzymes, indicating that there is one M-OVO gene
in the mouse genome (data not shown). Taken together, M-
OVO-A and M-OVO-B are probably generated from a single
gene by an alternative splicing event.
The longest open reading frame of M-OVO-A, in which the
¢rst ATG (position 1 in Fig. 1A) is assigned as an initiation
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Fig. 2. Comparison of M-OVO with Drosophila ovo and other zinc ¢nger proteins. A: Amino acid sequence comparison of zinc ¢nger domain.
Ovo, Drosophila Ovo protein; XLcOF28, Xenopus oocyte zinc ¢nger protein XLcOF28 [25]; mfg2, mouse zinc ¢nger protein mfg2 [26]; HKR1,
human kruºppel-related zinc ¢nger protein 1 [27]. Cysteine and histidine residues constituting the zinc ¢nger motifs are presented in bold type.
Dashes represent identity to M-OVO. Black squares highlight the DNA contact amino acids as determined by the model of Klevit [28].
B: Schematic comparison of Drosophila ovo protein and M-OVO-A and -B. The zinc ¢nger domain and serine-rich region are labeled as ZF
and S. C: Phylogenetic tree of M-OVO-A and other zinc ¢nger proteins. On the basis of the distance matrix between aligned amino acid
sequences, the tree was inferred by the UPGMA method [33]. The numbers indicate the distance from each branching point. XLcGF26 and
XLcGF7, Xenopus gastrula zinc ¢nger proteins [25].
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codon, encodes a 31-kDa protein of 274 amino acids. The
nucleotide sequence around the ¢rst methionine of M-OVO-
A ¢ts well the consensus sequence for translational initiation
in higher eukaryotes [24]. The predicted protein contains four
clusters of C2H2 type zinc ¢ngers at the carboxy-terminus
(between amino acids 120 and 236), and a domain which is
rich in acidic amino acids and serine (acidic/serine-rich do-
main, between amino acids 11 and 90). On the other hand,
due to the di¡erence in nucleotide sequence of the 5P terminal
region, the ¢rst methionine (position 1 in Fig. 1B) assigned as
an initiation codon of M-OVO-B corresponds exactly to the
methionine at position 96 of M-OVO-A. Consequently, M-
OVO-B encodes a truncated isoform of M-OVO-A of 21
kDa consisting of 179 amino acids, which possesses the iden-
tical zinc ¢nger domain as M-OVO-A, but lacks the acidic/
serine-rich domain.
A search of the computer databases for nucleotide and
amino acid sequences was conducted. As expected, the highest
matches of both sequences were to the ovo gene and its prod-
uct, and to a much lesser degree to other zinc ¢nger proteins
such as Xenopus zinc ¢nger proteins, XLcOF28 [25], XLcGF7
[25], XLcGF26 [25], mouse mfg2 [26] and human kruºppel-
related protein, HKR1 [27]. An amino acid alignment of their
zinc ¢nger domains is shown in Fig. 2A. There is a high
degree of sequence identity between M-OVO and Ovo protein
(68%, 80/117), particularly in the region excluding zinc ¢nger
IV (74%, 70/95). The amino acids considered to contact the
DNA strand are marked by boxes [28]. Considering the fact
that erythroid kruºppel-like factor, exhibiting 58% amino acid
identity with SP I in the zinc ¢nger domain consisting of three
C2H2 motifs, binds the same CACCC site in the L-globin gene
promoter [29], M-OVO and Ovo protein would bind to a
similar and perhaps identical DNA sequence. Similar to
Ovo protein, the M-OVO zinc ¢nger domain does not contain
a typical TGEKPY(Y/F) consensus sequence in each H/C
link, which is well conserved in the kruºppel-type zinc ¢nger
motif and ubiquitously present in the mammalian genome
[30].
A schematic comparison of M-OVO and Ovo protein is
shown in Fig. 2B. M-OVO-A is much smaller than Ovo pro-
tein, and it lacks characteristic polyamino acid stretches such
as polyglutamine [16]. However, a similar serine-rich sequence
(between amino acids 49 and 72) is also present at the amino-
terminal portion just adjacent to the zinc ¢nger domain. As an
acidic amino acid or serine-rich domain is known to act as an
activation domain in several transcription factors [31,32], the
whole structural feature suggests that M-OVO-A may be a
transcription factor which possesses high similarity to Ovo
protein. To establish evolutionary relationships among the
zinc ¢nger proteins showing high homology with M-OVO-
A, a phylogenetic tree was constructed by the UPGMA meth-
od [33] (Fig. 2C). M-OVO-A and Ovo protein form a single
cluster which is separated from that of other proteins, indicat-
ing that they constitute a closed subfamily within the large
zinc ¢nger gene family.
To examine the intracellular localization of M-OVO, we
carried out transient expression of epitope-tagged M-OVO-A
and M-OVO-B followed by indirect immuno£uorescence us-
ing a monoclonal antibody against the HA tag (Fig. 3). Both
transfected cells showed strong immuno£uorescence in the
nucleus in positive cells.
As shown in Fig. 4A, 1.3-kbp mRNA of M-OVO is pre-
dominantly expressed in testis, but apparently not in embryos
(data not shown) or ovary where ovo mRNA is restrictedly
expressed in fruit £y. Although it is often observed that the
tissue distribution and expression level of mammalian homo-
logues are di¡erent from those of the vertebrate genes, they
are commonly expressed in similar crucial tissues where Dro-
sophila genes play essential roles. Concerning the apparent
absence of M-OVO transcript in ovary, M-OVO may be a
structurally homologous protein but not be the homologue
of ovo involved in ovary development. However, since the
mammalian ovary is heterogeneous tissue consisting of di¡er-
ent types of cells at various developmental stages, the possi-
bility of restricted or temporary regulated expression of M-
OVO in ovary should also not be excluded.
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Fig. 3. Nuclear localization of epitope-tagged M-OVO-A and -B.
After blocking the ¢xed cells under permeabilized condition, they
were incubated with anti-HA monoclonal antibody 12CA5, followed
by detection with rhodamine-conjugated anti-mouse IgG antibody.
Immuno£uorescence (A-C) and bright-¢eld (AP-CP) photomicro-
graphs of COS-7 cells transfected with pCG-HA-M-OVO-A (A and
AP), pCG-HA-M-OVO-B (B and BP), and control pCG-HA (C and
CP).
Fig. 4. Northern blot analysis of M-OVO. A: Tissue distribution of
M-OVO mRNA. Poly(A) RNAs of each tissue (2 Wg) are analyzed.
Br, brain; He, heart; Sp, spleen; Lu, lung; Li, liver; Mu, skeletal
muscle; Ki, kidney; Te, testis; Ov, ovary. B: Analysis of M-OVO
expression during testis development. 20 Wg of total RNA of testis
are analyzed. 2W, 2-week-old mice; 3W, 3-week-old mice; 6W, 6-
week-old mice. 28S and 18S rRNAs are indicated on the left side.
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To determine whether the M-OVO mRNA is regulated dur-
ing development of testis, we prepared total RNA from mouse
testis at di¡erent stages of sexual maturation, i.e. a 14-day-old
prepubertal mouse, a 21-day-old mouse and a sexually mature
adult mouse. As shown in Fig. 4B, although no M-OVO
mRNA was detected in prepubertal mouse testis, it showed
a dramatic increase in 21-day-old mouse testis. Mammalian
spermatogenesis is a continuum of cellular di¡erentiation in
which three principal phases can be discerned: spermatogonial
renewal and proliferation, meiosis, and spermiogenesis, and it
is initiated shortly after birth [34]. The ¢rst wave of di¡er-
entiating germ cells have entered early prophase (i.e. leptotene
and zygotene) at around day 14, and reached spermatid stage
at day 21 [34]. The clear onset of increased M-OVO expres-
sion between days 14 and 21 (Fig. 4B) implies that M-OVO
may play an important role in the development of testis, pos-
sibly in late meiotic or post-meiotic phases of spermatogene-
sis. Some ovo mutants produce small tumors in which germ
cells closely resemble early spermatocytes [10,11]. It might be
possible that M-OVO gene regulates some unknown process
of germ line development which is partly shared between
mammals and invertebrates.
The alternative splicing of transcripts or alternative usage
of translation initiation sites leads to the generation of multi-
ple isoforms of transcription factors which exhibit di¡erent
abilities to bind target DNA or to transactivate target genes
[35,36]. The interaction of the isoforms is also considered to
play important roles in regulating cell di¡erentiation [35,36].
In regulation of terminal liver di¡erentiation, the transcrip-
tional activation of the target gene by the liver enriched acti-
vation protein, LAP, possessing both a DNA binding domain
and an activation domain, is modulated by its isoform, the
liver inhibitory protein, LIP, possessing only a DNA binding
domain in dominant negative fashion [36]. Similarly, M-OVO-
A and -B are isoforms with or without the putative activation
domain, implying that M-OVO-A and -B may be an activa-
tion form and an inactivation form, respectively. Therefore, if
both forms are expressed in the same cell, they might compete
for the binding sequence and regulate the activation of the
target gene.
It has recently been reported that chromosome III of the
nematode genome contains a sequence which can encode a
putative zinc ¢nger protein highly homologous to Ovo protein
and M-OVO [37]. Genetic analysis targeted to the gene loci in
the nematode might provide insights into the physiological
roles of M-OVO. Further investigations, including identi¢ca-
tion of target genes or gene transfer of M-OVO to Drosophila
ovo mutants to see whether the abnormalities are rescued, may
shed light on the mechanism(s) of controlling testis or germ
line development.
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